SCHEMBL5244170

SCHEMBL5244170

CC(C)(C)OC(=O)NCCn1c(=O)[nH]c2cc(Nc3ccccc3)ccc21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERCC1 P07992 1/20 0.42
DNASE1 P24855 1/20 0.42
FEN1 P39748 1/20 0.42
ERCC4 Q92889 1/20 0.42
BCHE P06276 1/20 0.40
IDO1 P14902 1/20 0.39
DRD2 P14416 1/20 0.39
CNR2 P34972 1/20 0.39
SIGMAR1 Q99720 2/20 0.39
APP P05067 1/20 0.39
AKT1 P31749 1/20 0.39
CACNA1G O43497 2/20 0.39
TDP1 Q9NUW8 1/20 0.38
NAMPT P43490 1/20 0.38
ADORA3 P0DMS8 1/20 0.38
ADORA1 P30542 1/20 0.38
OPRM1 P35372 1/20 0.38
OPRK1 P41145 1/20 0.38
MDM2 Q00987 1/20 0.38
BRD4 O60885 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL891197 0.84 BCHE (0.49) BCHEIDO1DRD2TDP1ADORA3
SCHEMBL5171827 0.79 BCHE (0.45) BCHEDRD2TDP1ADORA3ADORA1
SCHEMBL22605688 0.78 ADORA3 (0.55) BCHEDRD2CNR2TDP1ADORA3
SCHEMBL15183122 0.78 CNR2 (0.48) CNR2ADORA3ADORA1OPRM1OPRK1
SCHEMBL5243499 0.77 KMT2A (0.48) ERCC1DNASE1FEN1ERCC4APP
SCHEMBL897551 0.77 B3GNT2 (0.55) BCHEIDO1DRD2CNR2SIGMAR1
SCHEMBL14339563 0.76 KDM4E (0.50) ERCC1DNASE1FEN1ERCC4APP
SCHEMBL5243149 0.76 RAB9A (0.48) ERCC1DNASE1FEN1ERCC4APP
SCHEMBL5240660 0.76 ERCC1 (0.52) ERCC1DNASE1FEN1ERCC4APP
SCHEMBL5242487 0.76 ERCC1 (0.49) ERCC1DNASE1FEN1ERCC4APP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7115644-B2 Heterocyclic compounds BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) 2006-10-03 US claimed
EP-1539708-B1 BENZIMIDAZOLONES AND THEIR USE AS CYTOKINE INHIBITORS BOEHRINGER INGELHEIM PHARMA (US) 2007-12-26 EP disclosed
EP-1539708-B1 BENZIMIDAZOLONES AND THEIR USE AS CYTOKINE INHIBITORS BOEHRINGER INGELHEIM PHARMA (US) 2007-12-26 EP disclosed
US-7115644-B2 Heterocyclic compounds BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) 2006-10-03 US disclosed
EP-1539708-A1 BENZIMIDAZOLONES AND THEIR USE AS CYTOKINE INHIBITORS BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) 2005-06-15 EP disclosed
WO-2004024699-A1 BENZIMIDAZOLONES AND THEIR USE AS CYTOKINE INHIBITORS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2004-03-25 WO disclosed